http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007030658-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d53094985a54e1cafd22f23d76be4007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72612bac0c729f0643f498e772950676 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate | 2006-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67c6107ae3ce1535cd7ac8cb93a15b21 |
publicationDate | 2007-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2007030658-A2 |
titleOfInvention | Compositions useful for and methods of modulating angiogenesis |
abstract | Compositions and methods for treating subjects with disorders characterized by aberrant vascular endothelial cell growth are provided. The compositions comprise agents that are combinations of a Wnt pathway stimulator component and a Tie2 pathway repressor component. Particularly useful Wnt pathway stimulators include, but are not limited to, Wnt7b-like molecules. Particularly useful Tie2 pathway repressor components include, but are not limited to, Ang2-like molecules. The methods allow for modulation of vascular endothelial cells, vascular endothelial cell vessels, capillary bed development, and angiogenesis. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008134632-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2021473-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2021473-A1 |
priorityDate | 2005-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 234.